Application of Core Technologies to Electronic Devices and Other Fields
First written in FY2016. 7 of 18 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2021: 2 of 23 companies on the "Worse" side.
7 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「In addition, to contribute to people's lives and health through surface modification, we are advancing the expansion of new technologies into the medical and life sciences fields. We are also actively applying surface treatment technologies that add high-value-added functions, including insulation, thermal insulation, water repellency and antibacterial properties, to new markets such as electronic components, consumer products and medical devices. Further market expansion is expected going forward.」
The company continues to expand its core technologies and develop applications for high-value-added functions in medical and life sciences, electronic components, consumer products and other fields. - FY2026-H1AdvancedAnnual report
「As Parker MedTech株式会社 was established through an incorporation-type company split during the current interim consolidated accounting period, it has been included in the scope of consolidation.」
Expansion into the medical device and life sciences fields advanced from a plan to establish a company by separating the Medical Devices Department to the implementation stage, with Parker MedTech株式会社 established as a consolidated subsidiary. - FY2025AdvancedAnnual report
「In addition, to develop and strengthen the sales structure for medical devices that use our surface modification technologies, our Board of Directors decided in March 2025 to establish Parker MedTech株式会社 in July 2025 by separating the Medical Devices Department of our Life Sciences Division into an independent company through a company split.」
With respect to expansion into the life sciences and medical device fields, the company decided on a concrete organizational step: separating the Medical Devices Department through a company split and establishing Parker MedTech. - FY2023AdvancedAnnual report
「In addition, by developing coating treatment technologies that deliver new functions, including insulation, thermal insulation, water repellency and antibacterial properties, through the application of our core technologies, and by creating new core technologies, we are actively pursuing application development in new markets such as electronic components, consumer products and medical devices. Further market expansion is expected going forward.」
The company continues to give concrete form to electronic components, consumer products and medical devices as target applications for its core technologies, while advancing the development of new functions and applications. - FY2022AdvancedAnnual report
「In addition, by developing coating treatment technologies that deliver new functions, including insulation, thermal insulation, water repellency and antibacterial properties, through the application of our core technologies, and by creating new core technologies, we are actively pursuing application development in new markets such as electronic components, consumer products and medical devices.」
The company continues to develop and give concrete form to functions including insulation, thermal insulation, water repellency and antibacterial properties, as well as applications for electronic components, consumer products and medical devices. - FY2022-Q2RestatedAnnual report
「As part of our life sciences business, we began selling the antibacterial agent “Pal-feel” to general consumers last year. At the same time, we have been advancing our entry into the medical device market by manufacturing and selling electrosurgical components “CHIDORI” with reduced adhesion of blood and biological tissue through our proprietary coating technology, as well as providing surface treatment processing for catheter guidewires.」
The company continues to expand into the life sciences and medical device fields through the antibacterial agent, electrosurgical components and surface treatment processing for catheter guidewires. - FY2022-Q1AdvancedAnnual report
「As part of our life sciences business, we began selling the antibacterial agent “Pal-feel” to general consumers last year. At the same time, we have been advancing our entry into the medical device market by manufacturing and selling electrosurgical components “CHIDORI” with reduced adhesion of blood and biological tissue through our proprietary coating technology, as well as providing surface treatment processing for catheter guidewires.」
The company has specified surface treatment processing for catheter guidewires in addition to the antibacterial agent Pal-feel and the electrosurgical component CHIDORI, giving concrete form to its expansion into the medical device and life sciences fields. - FY2021-Q3AdvancedAnnual report
「As part of our life sciences business, we began selling the antibacterial agent Pal-feel to general consumers. At the same time, we have been advancing our entry into the medical device market, launching electrosurgical components with reduced tissue adhesion using our proprietary coating technology, and receiving the Health, Welfare, Biotechnology and Medical Device Components Award at the 2020 “Super” Monozukuri Parts Awards.」
The company describes concrete progress in expanding its core technologies into new markets, including the launch of sales of the antibacterial agent Pal-feel, the commercialization of electrosurgical components for medical devices, and the receipt of an award. - FY2020RaisedAnnual report
「In addition, by developing coating treatment technologies with new functions, including insulation, thermal insulation, water repellency and antibacterial properties, using our core technologies, we are actively pursuing application development in new markets such as electronic components, consumer products and medical devices.」
In addition to the existing insulation, thermal insulation and water-repellent functions, the company has highlighted antibacterial properties and expanded its application scope to electronic components, consumer products and medical devices. - FY2019AdvancedAnnual report
「In new markets, we have also developed coating treatment technologies with new functions, including insulation, thermal insulation and water repellency, by applying our core technologies, and have pursued the development of applications for them.」
The company is advancing development to expand its core technologies into new functions and applications, including insulation, thermal insulation and water repellency. - FY2018-Q1RestatedAnnual report
「The Company is also focusing on research and development activities, including strengthening basic research aimed at creating core technologies in order to secure future market competitiveness.」
The company continues to expand its technologies into new markets and applications through the creation of core technologies and the strengthening of basic research. - FY2017RestatedAnnual report
「In new markets, we have studied technologies to meet new performance requirements, including insulation and thermal insulation, using our core technologies, and have pursued the development of applications for them.」
The company continues R&D to expand its core technologies into new applications, including insulation and thermal insulation. - FY2017-Q3RestatedAnnual report
「We are also focusing on research and development activities, including the development of surface treatment agents for new markets and the enhancement of basic research, in order to secure future market advantages.」
The company continues to expand its core technologies through the development of surface treatment agents for new markets and the strengthening of basic research. - FY2017-Q2RestatedAnnual report
「We are also focusing on research and development activities, including the development of surface treatment agents for new markets and the enhancement of basic research, in order to secure future market advantages.」
The company continues to expand its core technologies through the development of surface treatment agents for new markets and the strengthening of basic research. - FY2017-Q1RestatedAnnual report
「We are also focusing on research and development activities, including the development of surface treatment agents for new markets and the enhancement of basic research, in order to secure future market advantages.」
The company is reaffirming its R&D initiative to expand the development of surface treatment agents into new markets. - FY2016First statedAnnual report
「In new markets, we have pursued expanded applications of PALMIC, a self-depositing resin coating technology, for electronic devices and related products, while developing technologies to meet new performance requirements, including insulation and thermal insulation, using our core technologies.」
Initiatives to expand existing core technologies into electronic devices and related products, and insulation and thermal insulation applications.